Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer

PHILADELPHIA, PA, May 4, 2023 – (ACN Newswire) – Envision Pharma Group (Envision) has appointed Dr. Jennifer Costello, PharmD, BCPS, CMPP, to the role of Chief Medical Officer. Jennifer will be responsible for progressing work across all sectors of Envision's business, including Technology, Medical, Commercial, Public Affairs, and Value & Access and Data Analytics.

Meg Heim, CEO of Envision Pharma Group, adds, "I am so excited to welcome Jennifer to the Envision team as Chief Medical Officer. Jennifer's deep expertise in science and commercialization in the life sciences industry, in addition to her extensive pharmaceutical understanding and experience will further support the acceleration of our business expansion, mission, and commitment to our vision as a technology-enabled partner to the life sciences industry."

Jennifer is an accomplished pharmaceutical and healthcare leader with over 20 years of experience across the healthcare sector. She brings to this role extensive cardiovascular, medical, and patient care-related focused expertise, with a successful track record of leading high-performing cross-matrix teams with global impact.

Prior to joining Envision, Jennifer held multiple leadership roles in global medical affairs and publications, US HEOR publications, and global scientific content. She developed a reputation for leading successful partnerships with cross-functional colleagues, advocacy partners, and academic groups that resulted in building innovative programs that foster healthcare transformation.

Jennifer joins Envision from Bristol Myers Squibb, where she most recently led cardiovascular (CV) patient advocacy across its CV portfolio (early phase assets to marketed products). She drove the development and execution of global and US strategies for a successful launch of a first-in-class CV asset, working across early asset development, commercial, and medical affairs teams. For her work in this space, she was awarded the coveted "Innovation Award" from BMS.

Before joining the pharmaceutical industry, her 16 years of experience as a practicing clinical pharmacist was within the academic medical-teaching hospital. Jennifer served in numerous roles as a pediatric critical care specialist, adult ambulatory clinical care specialist, hospital administrator, and as a Director of Clinical Pharmacy Services. Under a collaborative practice agreement, she also led outpatient care optimization, directly co-managing heart failure, antithrombotic, and diabetic patients.

Jennifer received her PharmD from Northeastern University, completed her ASHP PGY-1 residency at the University of Arizona/University Medical Center, and received her board certification as a pharmacotherapy specialist from the American College of Clinical Pharmacy. She served in adjunct teaching positions with Rutgers University and the University of Florida. She has authored over 50 publications and posters and served as a pharmacy national thought leader within the heart failure, antithrombotic, and diabetes management space.

Jennifer adds, "I am delighted and humbled to join the Envision team during this transformative time. I am looking forward to meeting and working with our Envision family, customers, and partners. This is an exciting period for our industry at large, and I am privileged to build upon our company vision, award-winning technology, and innovation as medical affairs and global healthcare communication leaders."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856

SOURCE: Envision Pharma Group

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Empower Your HR Strategy with Infocus International’s Virtual Workshop

Singapore, May 4, 2023 – (ACN Newswire) – Infocus International Group is thrilled to announce the launch of its brand-new virtual workshop, Strategic Human Resource Management, starting on 13^th June 2023.

This exciting new course is the next level in managing people in organizations. An advanced HR course, attendee’s itinerary is focused on framing the urgent and complex contemporary challenges facing HR professionals in a strategic framework. The big question this course answers is: How and in what ways can HR professionals deliver value and contribute to the achievement of the company’s wider strategic goals while navigating people through the complexities and uncertainties of a fast-changing future?

Strategic HR is about aligning HR initiatives with the broader strategic goals and plans of the organization. Strategic HR leads from the front and drives change rather than reacts to it, and strategic HR both saves and makes the company money. This dynamic course explores several key areas where HR has the opportunity to play strategic lead and drive positive change for the organization through the employees and how they work. These new frontiers pose a challenge for HR professionals as for many of us, this is new territory. This course is the help, advice and solutions you are looking for.

Guided by a leading international expert, and through uncovering global best practice examples and experiences from major companies, attendees will explore the challenges and possibilities of:

Discovering the latest trends, challenges and solution in emerging HR topics
Gaining insights into how leading iconic companies are addressing pressing challenges
Receiving high-quality learning pack of 150+ PPT slides, usable models, articles, industry cases, assessment tools and take-away bonus booklets
Acquiring real knowledge and skills to begin future-proofing your most valuable resource – employees
Seeking advice and guidance on specific projects, challenges, or dilemmas that you are facing in your role
Building relationships and expanding your professional network by meeting diverse range of professionals attending the program
Achieving distinct competitive advantage over your competitors by tackling challenges and providing solutions for tomorrow’s HR issues

This cutting-edge course is designed to equip HR professionals with the essential skills and knowledge required to excel in the rapidly evolving field of human resource management. Through live 5 online sessions, attendees will learn from seasoned industry experts and gain valuable insights into the latest HR trends and best practices, empowering them to take their careers to the next level. Don’t miss this opportunity to unlock your full potential in human resource management – enroll now for InFocus International’s Strategic Human Resource Management Online Course.

Benefits of Attending

Leading people and your company successfully through a range of different crises
Embracing leading edge technologies to deliver better HR services for customers and employees
Building robust solutions to ever-growing costly problem of poor employee mental health
Realizing and maximizing the hidden potential of an ageing workforce for competitive advantage
Assessing the costs and benefits of strategic HR outsourcing and offshoring to streamline the business and better manage costs
Monitoring and surveillance techniques for increased employee safety, compliance and productivity
Embracing Green HRM and realizing the many benefits it offers
Understanding and leveraging the employer’s hand in the all-important psychological contract we have with each employee
Learning from global best practice through case studies and industry examples sharing the ‘secrets’ from leading iconic companies such as: Siemens, PayPal, Bayer, Bank of America, Google, McDonalds, Amazon, IBM, Hilton, US Air force, and many more

Want to learn more?

Simply email esther@infocusevent.com or call +65 6325 0210 to obtain your FREE COPY of event brochure. For more information, please visit https://www.infocusinternational.com/hrm

About Infocus International Group

Infocus International is a global business intelligence provider of strategic information and professional services for diverse business communities. We recognise clients’ needs and responds with innovative and result oriented programmes. All products are founded on high value content in diverse subject areas, and the highest level of quality is ensured through intensive and in-depth market research from local and international insights. For more information: www.infocusinternational.com

Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics

PHILADELPHIA, PA, May 2, 2023 – (ACN Newswire) – Envision Pharma Group (Envision) has appointed Mike Glover to Senior Vice President, Payer and HTA Solutions. Mike will be responsible for leading and developing Envision's distinctive market access and HTA strategies for early-stage and late-stage businesses, combining customer insights, vision, and creativity. Mike's key focus areas will be transformations in patient access, global pricing strategies, real-world evidence, and improving patient outcomes.

Meg Heim, CEO of Envision Pharma Group, shares, "I am excited to welcome Mike to the team at Envision as Senior Vice President, Payer and HTA solutions. As we continue to accelerate Envision's business expansion, mission, and commitment to our clients' needs. Mike's extensive experience in developing and executing cutting-edge access, policy, and pricing strategies while executing fully integrated market access programs will be critical in partnering with our clients to execute upon their goals, improve performance, and meet their unique business needs with the support of our technology platforms."

Prior to joining Envision, Mike served as Vice President, Head of Global Access and Pricing Strategy for GlaxoSmithKline. Before that, he held various leadership positions of increasing responsibilities at GSK, Sanofi, and Bristol Myers Squibb. He brings with him a diverse background across multiple geographies, functions, and therapeutic areas. His global commercial leadership experiences spanning oncology, cardiovascular, diabetes, and virology from asset development to in-market delivery will be a valuable asset to Envision.

Mike adds, "The energy and passion of the Envision team shines through in every interaction I've had. It was this passion and desire to be the very best at what they do that made this an easy decision for me to join Envision. Our industry is facing a changing and challenging environment and Envision is building an organization that will not just deliver, but will become a true partner for our customers adding real value across the life cycle of a brand. I am delighted to be joining them at this important time in our industry's future."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information:
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856

SOURCE: Envision Pharma Group

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

CleverTap names Pravin Laghaate as Vice President, Europe, and UK

Mountain View, Calif., London, UK, Amsterdam, Netherlands, & Mumbai, India, Apr 25, 2023 – (ACN Newswire) – CleverTap, world's #1 retention cloud, today named Pravin Laghaate as Vice President for its Europe and United Kingdom regions. Pravin, who joined CleverTap in 2020 and has been in senior leadership sales roles centrally, will now oversee sales, go-to-market strategy, and execution across Europe and the UK.

CleverTap names Pravin Laghaate as Vice President, Europe, and UK

With over 20 years of experience across markets, he has been instrumental in establishing new benchmarks for expansion revenue and client engagement at CleverTap. Pravin has successfully built and led high-performance sales teams, in the past and worked with prominent brands such as Vodafone, Kingfisher Airlines, Gulf Air and Emirates.

"The UK and Europe's SaaS market is set to cross US$100 billion within the next decade. Given the immense potential within these regions we are certain that Pravin's elevation will allow us to continue on our high-growth journey. His presence within the region will be instrumental in driving customer retention and engagement for our European and UK based customers, enabling them to reach newer heights." said Sidharth Malik, Chief Executive Officer, CleverTap. "With a resilient business strategy, and drive to innovate, we are all set to further bolster our global footprint within the burgeoning SaaS landscape." he added.

Talking about his new role Pravin states that, "I am ecstatic to be entrusted with the responsibility to grow our business in this region. CleverTap is the fastest growing retention cloud platform in the world, strengthening our footprint in the UK and Europe is going to be key to achieving our global ambitions."

About CleverTap

CleverTap is the all-in-one customer engagement platform that helps brands personalize and optimize all consumer touch points to improve user engagement, retention, and lifetime value. It's the only solution built to address the needs of retention and growth teams, with audience analytics, deep-segmentation, multi-channel engagement, product recommendations, and automation in one unified product.

The platform is powered by TesseractDB(TM) – the world's first purpose-built database for customer engagement, offering both speed and economies of scale.

CleverTap is trusted by 2000 customers, including Electronic Arts, TiltingPoint, Gamebasics, Big Fish, MobilityWare, TED, English Premier League, TD Bank, Carousell, AirAsia, Papa John's, and Tesco.

Backed by leading investors such as Sequoia India, Tiger Global, Accel, and CDPQ the company is headquartered in Mountain View, California, with presence in San Francisco, New York, Sao Paulo, Bogota, London, Amsterdam, Sofia, Dubai, Mumbai, Singapore, and Jakarta. For more information, visit clevertap.com or follow on LinkedIn and Twitter.

Forward-Looking Statements

Some of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.

Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.

For more information:
SONY SHETTY
Director, Public Relations, CleverTap
+91 9820900036
sony@clevertap.com

IPSHITA BALU
Consultant
Archetype
+91 9590111798
ipshita.balu@archetype.co

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Optimas Appoints Industry Veteran Phil Battaglia as Chief Financial Officer

WOOD DALE, IL, Apr 18, 2023 – (ACN Newswire) – Optimas Solutions, a global industrial manufacturer/distributor and service provider, announced today the appointment of Phil Battaglia as Chief Financial Officer. Battaglia possesses over 25 years of financial management and reporting expertise, most recently leadership experience at Caterpillar Inc.

Phil Battaglia, CFO of Optimas Solutions. Phil Battaglia comes from Caterpillar to become Optimas Solutions' new CFO.

"We are delighted to have Phil on board in such an important role for us," said Daniel Harms and Mike Tuffy, Optimas' dual CEOs. "As we continue to elevate our business, we needed someone in our CFO position with the financial acumen and customer-oriented thinking that Phil brings to us. We believe Phil will be essential to strengthening Optimas' solid financial foundation and partner with us to ultimately enhance how we serve our customers."

"Optimas is well positioned for a successful future driven by our customers' needs," Battaglia said. "I think I can bring that customer perspective to Optimas given my experience at Caterpillar. While I was there, I worked with suppliers such as Optimas and understand what OEMs want and need. I'm excited about the long-term impact of the Optimas team, its products and processes, not only for us, but more importantly for our customers."

Battaglia comes to Optimas from Caterpillar, where he held various positions including Vice President of Financial Planning & Analysis, CFO of Caterpillar's Product Support & Logistics Division, and Assistant Corporate Treasurer. Prior to Caterpillar, he was an investment banker at Citi where he advised customers in the industrials and mining sectors on M&A and financing transactions. Battaglia holds a BA degree in economics from Northwestern University and is certified by The Institute of Management Accountants.

About Optimas Solutions

Optimas is the leading global industrial distributor and service provider specializing in fastening and supply chain solutions for manufacturers seeking to improve efficiency and profitability. We take care of the details so customers can focus on manufacturing cutting-edge products – giving them an unparalleled competitive edge. Visit optimas.com and follow us on LinkedIn www.linkedin.com/company/optimas-solutions/ and Twitter @Optimas_S.

Contact Information
Meghan Lane
Senior Marketing Manager
meghan.lane@optimas.com
+1 (630) 716-3416

Tom Bryan
Marketing Manager
tom.bryan@optimas.com
44 (0)7725 109294

SOURCE: Optimas Solutions

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Trintech Announces Appointment of Darren Heffernan as New CEO

DALLAS, TX, Apr 13, 2023 – (ACN Newswire) – Trintech, a leading global provider of cloud-based financial close solutions for the Office of Finance, today announced that Darren Heffernan, President & Chief Operating Officer, will become the company's next Chief Executive Officer, effective May 1, 2023. Heffernan will succeed Teresa Mackintosh, who will transition to Executive Chair of the Trintech Board of Directors, after a successful seven-year tenure leading the company.

Heffernan, who has been with Trintech since 2001, has held a number of strategic and corporate development roles throughout his tenure at the company. He has been instrumental in driving significant growth in his capacity as CFO and President & COO, as well as through his involvement in the company's international business expansion. Heffernan's diverse experience and deep industry knowledge will inform his stewardship of Trintech's continued focus on the company's operational excellence and commitment to client service, partnership and growth.

Prior to Trintech, Heffernan held various finance and operational positions, driving innovation with companies like GE, Paramount / Universal Studios, IAWS and Anglo American.

As Executive Chair, Mackintosh will continue to work closely with Heffernan and Trintech's leadership team to ensure a smooth and successful transition. She is steadfast in her commitment to advancing Trintech's position as a leading global SaaS provider for the Office of Finance.

"I am incredibly proud of all that we have accomplished over the past seven years," said Mackintosh. "The team's unwavering commitment to serving our customers and supporting our partners has been astounding. I am excited to now welcome Darren as Trintech's next CEO. Darren has been critical in driving Trintech's growth for over twenty years, and his passion for innovation and deep understanding of our company culture is unmatched. Darren's focus on operational excellence will help us to meet and exceed the evolving needs of our expanding client base while also driving Trintech's growth trajectory. I look forward to our continued partnership in my new role as Executive Chair."

"On behalf of the Board of Directors, I want to extend my sincerest gratitude to Teresa for her exemplary leadership throughout these past seven years," said Pete Rottier, Managing Director of Summit Partners. "Under her leadership, Trintech tripled its revenue, solidifying its position as a leader and trusted partner in the global SaaS market for the Office of Finance. The Board is looking forward to Trintech's continued growth under Darren's leadership. With his strong strategic, financial, and operational background, and clear dedication to the company's business and customers, we believe Darren is the ideal person to lead Trintech forward in the years to come."

"It is a tremendous honor to serve as Trintech's next CEO," said Heffernan. "Teresa has been an incredible leader and colleague, and I am privileged to have worked alongside her for the past several years. I want to thank both Teresa and the entire Board for their support and confidence. I look forward to continuing our commitment to deliver better solutions and innovative services for our clients, collaborating with our global partners, expanding our business with exciting new opportunities for growth and building the company with the help of our tremendous employees."

About Trintech

Trintech, a leading global provider of cloud-based, integrated reconciliation and financial close solutions for Finance & Accounting departments. From high volume transaction matching, to automating and managing balance sheet reconciliations, intercompany accounting, journal entries, close management tasks, to governance, risk and compliance – Trintech's portfolio of financial solutions, including its Cadency(R) Platform (for large enterprises) and Adra(R) Suite (for mid-market organizations), help manage all aspects of the reconciliation and financial close processes. Trintech's excellence in both innovation and client support have been recognized with a variety of awards over the years including most recently "Easiest to Do Business With" and "Fastest Implementation" in G2's Fall 2022 Report. Over 3,500 clients worldwide – including the majority of the Fortune 100 – rely on Trintech's solutions to enable their F&A operation to become a strategic partner to the business by controlling risk, driving efficiencies, and providing strategic insights.

Headquartered in Plano, Texas, Trintech has offices located across the United States, United Kingdom, Australia, Singapore, France, Germany, Ireland, the Netherlands, and the Nordics, as well as strategic partners in South Africa, Latin America, and the Asia Pacific. To learn more about Trintech, visit www.trintech.com or connect with us on LinkedIn, Facebook, Twitter and Instagram.

Media Contact:
Kelli Shoevlin
Director, Global Corporate Marketing & Communications
kelli.shoevlin@trintech.com

SOURCE: Trintech

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies

Philadelphia, PA, Apr 12, 2023 – (ACN Newswire) – As U.S. health systems continue to struggle with a chronic nursing shortage, the National Council of State Boards of Nursing and CGFNS International, a global leader in international credentials evaluation to support health professional mobility, are expanding their collaboration to help expedite credentials verification while boosting fraud detection and ensuring patient safety.

The cooperative effort will focus on information-sharing between the two organizations and technology improvements aimed at creating efficiencies that will streamline credentials verification for nurses applying to work in a new jurisdiction. This comes as state nursing boards across the U.S. face growing pressure to accelerate verification processes and enable nursing staff vacancies to be filled more quickly.

Meanwhile, with growing numbers of foreign-trained nurses applying to work in the United States, the collaboration will also aim to improve efficiencies in verifying their qualifications and shorten approval times, while also improving the capabilities of verification systems to detect fraudulent activities. To further strengthen fraud protection and ensure patient safety, the two organizations will work to facilitate data-sharing between CGFNS' worldwide credentials verification systems and NCSBN's online tools that member boards use to share information about imposter and/or fraudulent nurses.

"Together, we want to vastly reduce the time-consuming manual processes that nursing schools, licensing authorities and nurses themselves must go through to gather and verify transcripts, examination scores, licenses and other information that is essential to ensuring that nurses are qualified to practice," said Peter Preziosi, President and CEO of CGFNS International.

"At a time when health systems are struggling to fill nursing staff vacancies, this collaboration will help expand the flow of qualified nurses to where they are needed by making verification systems more efficient, while hardening them against fraud," he added.

"Our members, the state nursing boards, face the enormous challenge of shortening the time it takes to access the necessary information needed to gain licensure, while also ensuring the integrity of the health workforce and patient safety. The steps we are taking to interface our systems with CGFNS will help us achieve both of those goals," said David Benton, Chief Executive Officer of the NCBSN.

About CGFNS International, Inc.

Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. For more information, visit www.cgfns.org.

About NCSBN

Empowering and supporting nursing regulators across the world in their mandate to protect the public, NCSBN is an independent, not-for-profit organization. As a global leader in regulatory excellence, NCSBN champions regulatory solutions to borderless health care delivery, agile regulatory systems and nurses practicing to the full scope of their education, experience and expertise. A world leader in test development and administration, NCSBN's NCLEX(R) Exams are internationally recognized as the preeminent nursing examinations.

Contact Information:
Mukul Bakhshi, Esq.
Chief of Strategy and Government Affairs
mbakhshi@cgfns.org
(215) 243-5825

SOURCE: CGFNS International

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Cleverbridge Appoints Dr. Markus A. Wesel as Its Chief Financial Officer

Cologne, Germany, Apr 3, 2023 – (ACN Newswire) – Cleverbridge is pleased to appoint Dr. Markus A. Wesel as its new Chief Financial Officer.

Dr. Markus A. Wesel, Cleverbridge Chief Financial Officer

Markus joins at an exciting time for Cleverbridge and marks another important step in Cleverbridge's journey to becoming the internet's leading customer success platform.

He is the latest addition to Cleverbridge's experienced and innovative leadership team consisting of CEO Wendi C. Sturgis, CTO Radu Immenroth, CCO Happy Luther, CPO Alexander Brochier, and CSO JC Capote.

Cleverbridge was founded in Cologne, Germany, and Chicago, Illinois, in 2005. Since then, Cleverbridge has grown to 300+ employees worldwide with 1.5 million monthly transactions and joined forces with equity partners EMH in 2020.

"I am excited to join Cleverbridge as it continues to grow and strive to make it easy for our clients to grow their revenue and customer lifetime value. I am confident that we can continue to grow profitability and take the next step as we continue establishing ourselves as the leaders in this space," Markus said. "There is an excellent and stable financial platform and team to enable the ambitious growth and development targets for 2023 and beyond."

Joining from CENIT, where he held the role of CFO, he brings 15 years of experience including capital market experience. Markus has held senior executive positions at several high-performing tech companies, having begun his career in the consulting world with PWC. He has also acted as an Associate Professor and Lecturer at several well-renowned German institutions.

"Cleverbridge has one of the world's leading all-in-one CLV Growth solutions for B2B and B2C companies, and we're excited to take the next step in our growth trajectory enabled by new technologies and our stable platform with an uptime of 99.99% in 2022," said Cleverbridge CEO, Wendi Sturgis. "With Markus joining the team, we are ensuring we can maintain our excellent financial platform and profitable growth trajectory."

More about Cleverbridge

Cleverbridge is the CLV Growth Company. We support customer success and sales teams to accelerate revenue growth and reduce churn without adding headcount. We do this by processing transactions and automating renewals without human intervention while augmenting your existing stack through the addition of AI-enabled automation to balance resource constraints. We provide you with all the solutions you will need to go to market in 180 markets worldwide successfully. For more information on Cleverbridge, please visit www.cleverbridge.com.

Contact Information:
Lennard Hulsbos
VP Marketing & Design
lennard.hulsbos@cleverbridge.com
+31639043809

SOURCE: Cleverbridge

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting

Philadelphia, PA, Mar 28, 2023 – (ACN Newswire) – Envision Pharma Group (Envision) has appointed Richard "Rich" Gorman to the role of President, Strategic Consulting and member of the Executive Leadership Team.

Rich is a 30-year veteran of the life sciences industry and a respected leader with a track record of success in pharmaceutical commercialization. He is an experienced head of high-performing teams that build go-to-market strategies to deliver on business development and revenue generation goals.

Rich will be responsible for leading the Strategic Consulting business across Envision's commercial, medical, and technology sectors. He will lead a team of scientific, medical, and commercial strategists with deep expertise in the life sciences industry while combining its technology and AI platforms to accelerate the business and scientific momentum of clients' strategies.

Prior to joining Envision, Rich served as Chief Commercial Officer and Global Head of Strategy for Amplity Health. Before that, he held various leadership positions and senior business development roles at Syneos Health. His background includes serving as a CEO for a specialty pharmaceutical company, as well as several positions within the field of contract pharmaceutical development and manufacturing.

Rich shares, "I am delighted to be joining Envision Pharma Group at this pivotal and exciting time. I am honored to have the opportunity to lead this talented team of strategy consultants. Combining their proven capabilities with the Envision technology platform will create a powerful option for manufacturers looking to efficiently bring new science and products to patients."

Meg Heim, Chief Executive Officer of Envision Pharma Group, states, "We are so excited to have Rich join our team as we continue to accelerate Envision's business expansion, mission, and commitment to our clients' needs. Rich's proven expertise will be critical in partnering with our clients to execute upon their goals, improve performance, and meet their unique business needs with the support of our technology platforms and strategic advisory expertise."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information
Colleen Carter
Communications
colleen.carter@envisionpharma.com
1 (508) 505 8856

SOURCE: Envision Pharma Group

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com